News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,316 Results
Type
Article (39003)
Company Profile (277)
Press Release (645036)
Section
Business (203845)
Career Advice (1987)
Deals (35359)
Drug Delivery (85)
Drug Development (80779)
Employer Resources (168)
FDA (16085)
Job Trends (14801)
News (344499)
Policy (32431)
Tag
Academia (2530)
Alliances (49053)
Alzheimer's disease (1219)
Approvals (16007)
Artificial intelligence (124)
Bankruptcy (352)
Best Places to Work (11505)
Biotechnology (196)
Breast cancer (114)
Cancer (995)
Cardiovascular disease (83)
Career advice (1657)
Cell therapy (213)
Clinical research (64045)
Collaboration (346)
Compensation (183)
COVID-19 (2523)
C-suite (86)
Data (977)
Diabetes (145)
Diagnostics (6116)
Earnings (84533)
Employer resources (146)
Events (109195)
Executive appointments (267)
FDA (16558)
Funding (309)
Gene therapy (159)
GLP-1 (569)
Government (4321)
Healthcare (18659)
Infectious disease (2604)
Inflammatory bowel disease (103)
Interviews (308)
IPO (16279)
Job creations (3623)
Job search strategy (1415)
Layoffs (410)
Legal (7851)
Lung cancer (159)
Manufacturing (160)
Medical device (13158)
Medtech (13163)
Mergers & acquisitions (19125)
Metabolic disorders (381)
Neuroscience (1470)
NextGen Class of 2024 (6497)
Non-profit (4463)
Northern California (1336)
Obesity (223)
Opinion (177)
Patents (96)
People (56173)
Phase I (19887)
Phase II (28203)
Phase III (21044)
Pipeline (328)
Postmarket research (2553)
Preclinical (8455)
Radiopharmaceuticals (234)
Rare diseases (196)
Real estate (5888)
Regulatory (21468)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1185)
Startups (3560)
United States (12478)
Vaccines (544)
Weight loss (164)
Date
Today (128)
Last 7 days (964)
Last 30 days (3326)
Last 365 days (35426)
2024 (31422)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (188)
Asia (37061)
Australia (6043)
California (3003)
Canada (1216)
China (234)
Colorado (130)
Connecticut (137)
Europe (79345)
Florida (418)
Georgia (107)
Illinois (328)
Indiana (188)
Kansas (96)
Maryland (549)
Massachusetts (2412)
Michigan (149)
Minnesota (260)
New Jersey (884)
New York (891)
North Carolina (676)
Northern California (1336)
Ohio (129)
Pennsylvania (790)
South America (1091)
Southern California (1185)
Texas (413)
Utah (84)
Washington State (338)
684,316 Results for "encision inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Encision Signs Master Services Agreement with Vicarious Surgical Inc.
August 21, 2024
·
2 min read
Business
Encision Reports Third Quarter Fiscal Year 2024 Results
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2024 third quarter that ended December 31, 2023.
February 14, 2024
·
6 min read
Press Releases
Encision Reports First Quarter Fiscal Year 2025 Results
August 16, 2024
·
5 min read
Press Releases
Encision Reports Fourth Quarter Fiscal Year 2024 Results
July 15, 2024
·
6 min read
Business
Encision Reports Second Quarter Fiscal Year 2024 Results
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2024 second quarter that ended September 30, 2023.
November 14, 2023
·
6 min read
BioMidwest
Encision Signs Proof of Concept Agreement with Vicarious Surgical Inc.
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced that Encision has signed a Proof of Concept Services Agreement with Vicarious Surgical Inc.
February 14, 2023
·
2 min read
Business
Encision Reports First Quarter Fiscal Year 2024 Results
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2024 first quarter that ended June 30, 2023.
August 3, 2023
·
5 min read
BioMidwest
Encision Signs Supplier Agreement with Human Xtensions
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced that Encision has signed a Supplier Agreement with Human Xtensions.
February 28, 2023
·
2 min read
Business
Encision Reports Fourth Quarter Fiscal Year 2023 Results
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2023 fourth quarter that ended March 31, 2023.
June 22, 2023
·
6 min read
Business
Encision Reports Third Quarter Fiscal Year 2023 Results
Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal year 2023 third quarter that ended December 31, 2022.
February 7, 2023
·
8 min read
1 of 68,432
Next
